×

Message

Resource not found

News

First insight into the revision of the EU pharma legislation 27-04-2021

 
Pharmaceuticals__2_2.jpg

ESIP responds to the evaluation roadmap-inception impact assessment

On 30 March the Commission launched the first stage of consultations with stakeholders towards the revision of the general pharmaceutical legislation, namely Directive 2001/83/EC1 and Regulation (EC) No 726/2004. ESIP submitted its first response to the evaluation roadmap-inception impact assessment touching upon several elements identified by the Commission to feed into future policy actions.

Promoting active & healthy ageing across the lifespan 20-04-2021

 
istockphoto-1008796894-612x612.jpg

ESIP responds to the Public Consultation on the Green Paper on Ageing

Social protection schemes in the EU are under strain as ageing increases demand for medical and long-term care (LTC) and old-age spendingIn this contextESIP provides its recommendations touching upon all branches of social security on how to tackle demographic change while fostering active and healthy ageing. 

 

3rd EMA-payer meeting on 12 March 2021 17-03-2021

 
3rd_EMA-payers_meeting_-_Agenda_-_Copy.png

Payers and EMA discussed evidence generation along the life-cycle of medicines

On 12 March, representatives from the European Social Insurance Platform (ESIP), the payer platform Medicines Evaluation Committee (MEDEV), the International Association of Mutual Benefit Societies (AIM) and the European Medicines Agency (EMA) met for the third time to further explore synergies and foster mutual understanding and cooperation on evidence generation, with the aim of better aligning evidence requirements for the different decision-making processes. On this occasion the focus was on evidence generation along the life-cycle of medicinal products.

More proposals on managing & preventing shortages 25-02-2021

 

New ESIP Paper on shortages of Medical Devices and PPE

In light of the lessons learned from COVID-19, ESIP welcomes and supports the reinforced European commitment to secure continuous supply of medicines, medical devices (MD) and personal protective equipment (PPE). In our recently adopted position paper we outline proposals for securing supply of MD and PPE, building upon our position on medicines shortages and taking stock of the measures specific to MD in the legislative proposals on Building an EU Health Union.